Saalman Lab’s study of ketamine and the brain published in Journal of Neuroscience

Ketamine has been shown to relieve depression-like symptoms in animal studies. With human volunteers, researchers Sounak Mohanta and Yuri Saalmann concluded that the drug blocks “negative predictions” that are prominent in depressed patients.